[HTML][HTML] T cell clonal dynamics determined by high-resolution TCR-β sequencing in recipients after allogeneic hematopoietic cell transplantation

M Leick, RM Gittelman, E Yusko, C Sanders… - Biology of Blood and …, 2020 - Elsevier
M Leick, RM Gittelman, E Yusko, C Sanders, H Robins, Z DeFilipp, S Nikiforow, J Ritz
Biology of Blood and Marrow Transplantation, 2020Elsevier
Delayed reconstitution of the immune system is a long-recognized complication after
allogeneic hematopoietic cell transplantation (HCT). Specifically, loss of T cell diversity has
been thought to contribute to infectious complications, graft-versus-host disease (GVHD),
and disease relapse. We performed serial high-resolution next-generation sequencing of T
cell receptor (TCR)-β in 99 related or unrelated donor (57 unrelated, 42 related) allogeneic
HCT recipients (55 with reduced-intensity conditioning, 44 with myeloablative conditioning) …
Abstract
Delayed reconstitution of the immune system is a long-recognized complication after allogeneic hematopoietic cell transplantation (HCT). Specifically, loss of T cell diversity has been thought to contribute to infectious complications, graft-versus-host disease (GVHD), and disease relapse. We performed serial high-resolution next-generation sequencing of T cell receptor (TCR)-β in 99 related or unrelated donor (57 unrelated, 42 related) allogeneic HCT recipients (55 with reduced-intensity conditioning, 44 with myeloablative conditioning) during the first 3 months after HCT using the immunoSEQ Assay. We measured T cell fraction, clonality (1- Peilou's evenness) and Daley-Smith richness from recipient samples at multiple time points. In agreement with previous studies, we found that although absolute T cell numbers recover relatively quickly after HCT, T cell repertoire diversity remains diminished. Restricted diversity was associated with conditioning intensity, use of antithymocyte globulin, and donor type. Increased number of expanded clones compared to donor T cell clones at day +30 was associated with the incidence of acute GVHD (hazard ratio [HR], 1.11; P = .00005). Even after exclusion of the 12 patients who developed acute GVHD before day +30, the association between acute GVHD and increased clonal expansion at day +30 remained (HR, 1.098; P = .041), indicating that increased clonal T cell expansion preceded the development of acute GVHD. Our results highlight T cell clonal expansion as a potential novel biomarker for acute GVHD that warrants further study.
Elsevier